360 ONE WAM Limited Files Q3FY26 Monitoring Agency Reports for Preferential Issues
360 ONE WAM Limited filed Q3FY26 monitoring agency reports for two preferential issues totaling ₹2,503.39 crores. The first issue of ₹391.59 crores (May 2025) allocated funds for debt repayment and corporate purposes, while the second issue of ₹2,111.80 crores (July 2025) targeted subsidiary investments. No funds were utilized during the quarter, with CARE Ratings confirming full compliance and no deviations from stated objectives.

*this image is generated using AI for illustrative purposes only.
360 one wam Limited has submitted monitoring agency reports for the quarter ended December 31, 2025, in compliance with SEBI regulations. The reports, prepared by CARE Ratings Limited, cover two separate preferential issues of equity convertible warrants totaling ₹2,503.39 crores.
First Preferential Issue Overview
The first preferential issue details and fund allocation are outlined below:
| Parameter: | Details |
|---|---|
| Issue Size: | ₹391.59 crores |
| Issue Period: | May 28, 2025 to June 3, 2025 |
| Type: | Equity Convertible Warrants |
| Amount Raised: | ₹97.90 crores |
| Monitoring Agency: | CARE Ratings Limited |
The funds from this issue are allocated for two primary purposes: repayment of company debt (₹293.69 crores) and other general corporate purposes (₹97.90 crores). During Q3FY26, no funds were called or utilized from this issue.
Second Preferential Issue Details
The larger second issue encompasses strategic investments across multiple subsidiaries:
| Parameter: | Details |
|---|---|
| Issue Size: | ₹2,111.80 crores |
| Issue Period: | July 15, 2025 to July 22, 2025 |
| Amount Raised: | ₹527.95 crores |
| Funds Allocated: | ₹527.95 crores |
The second issue proceeds are designated for investments in subsidiaries and corporate purposes:
- Investment in SEBI-registered stockbroker subsidiaries: ₹400.00 crores
- Investment in 360 ONE Prime Ltd.: ₹1,000.00 crores
- Investment in 360 ONE Alternates Asset Management Ltd.: ₹200.00 crores
- Other general corporate purposes: ₹511.80 crores
Compliance and Monitoring Status
Both monitoring reports confirm full compliance with regulatory requirements. CARE Ratings Limited reported no deviations from the stated objectives for either issue. All government and statutory approvals related to the fund utilization objectives have been obtained.
Key Compliance Highlights:
- No material deviations from offer document disclosures
- All shareholder approvals obtained as required
- No changes in financing means for disclosed objectives
- No major deviations from previous monitoring reports
Promoter Shareholding Update
The monitoring agency noted a significant change in promoter shareholding structure. Promoter shareholding declined from 14.20% as of March 31, 2025, to 6.26% as of September 30, 2025, due to reclassification of two promoters into the public category. No changes occurred in promoter shareholding during Q3FY26.
Implementation Timeline
All investment objectives for the second issue are scheduled for completion by the conclusion of FY 2027-28, while general corporate purposes from the first issue have a timeline until FY 2025-26. The monitoring agency reported no delays in implementation as of December 31, 2025.
The reports were presented to the company's audit committee and Board of Directors at their meeting held on January 15, 2026, and are available on the company's investor relations website.
Historical Stock Returns for 360 One WAM
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.09% | -3.18% | +0.61% | -3.75% | +4.29% | +323.14% |
















































